Tri Chemical Laboratories Inc. (TYO:4369)
3,800.00
+285.00 (8.11%)
Jun 15, 2026, 3:30 PM JST
Tri Chemical Laboratories Balance Sheet
Financials in millions JPY. Fiscal year is February - January.
Millions JPY. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jan '26 Jan 31, 2026 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 |
Cash & Equivalents | 7,798 | 7,279 | 9,439 | 10,497 | 11,137 | 8,034 |
Cash & Short-Term Investments | 7,798 | 7,279 | 9,439 | 10,497 | 11,137 | 8,034 |
Cash Growth | -2.42% | -22.88% | -10.08% | -5.75% | 38.62% | 373.15% |
Receivables | 6,027 | 6,509 | 5,219 | 4,035 | 4,561 | 3,896 |
Inventory | 7,066 | 7,865 | 5,975 | 4,022 | 2,740 | 2,150 |
Other Current Assets | 1,808 | 1,600 | 823 | 454 | 484 | 306 |
Total Current Assets | 22,699 | 23,253 | 21,456 | 19,008 | 18,922 | 14,386 |
Property, Plant & Equipment | 17,491 | 17,225 | 10,936 | 9,269 | 8,372 | 8,014 |
Long-Term Investments | 6,228 | 6,354 | 4,135 | 3,186 | 4,527 | 5,624 |
Other Intangible Assets | 83.49 | 89 | 74 | 105 | 134 | 181 |
Long-Term Deferred Tax Assets | - | 352 | 342 | 295 | 158 | 82 |
Other Long-Term Assets | 673.67 | 1 | 1 | 1 | 2 | 1 |
Total Assets | 47,174 | 47,274 | 36,944 | 31,864 | 32,115 | 28,288 |
Accounts Payable | 1,153 | 2,045 | 969 | 354 | 1,142 | 613 |
Accrued Expenses | 332.7 | 147 | 126 | 115 | 124 | 113 |
Current Portion of Long-Term Debt | 821.44 | 640 | 653 | 700 | 785 | 961 |
Current Portion of Leases | - | 122 | 105 | 102 | 91 | 90 |
Current Income Taxes Payable | 697.46 | 3,756 | 1,295 | 235 | 787 | 800 |
Other Current Liabilities | 1,845 | 894 | 1,034 | 1,047 | 746 | 888 |
Total Current Liabilities | 4,850 | 7,604 | 4,182 | 2,553 | 3,675 | 3,465 |
Long-Term Debt | 5,141 | 3,082 | 722 | 1,212 | 1,913 | 2,699 |
Long-Term Leases | - | 280 | 296 | 384 | 453 | 532 |
Pension & Post-Retirement Benefits | 147.14 | 157 | 155 | 143 | 133 | 118 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 62 | 152 |
Other Long-Term Liabilities | 274.05 | 3 | 2 | 3 | 4 | 3 |
Total Liabilities | 10,413 | 11,126 | 5,357 | 4,295 | 6,240 | 6,969 |
Common Stock | 3,279 | 3,278 | 3,278 | 3,278 | 3,278 | 3,278 |
Additional Paid-In Capital | 3,180 | 3,179 | 3,179 | 3,179 | 3,179 | 3,179 |
Retained Earnings | 29,388 | 28,669 | 24,291 | 20,304 | 18,809 | 14,626 |
Treasury Stock | -2.88 | -2 | -2 | -2 | -2 | -1 |
Comprehensive Income & Other | 917.85 | 1,024 | 841 | 810 | 611 | 237 |
Shareholders' Equity | 36,762 | 36,148 | 31,587 | 27,569 | 25,875 | 21,319 |
Total Liabilities & Equity | 47,174 | 47,274 | 36,944 | 31,864 | 32,115 | 28,288 |
Total Debt | 5,963 | 4,124 | 1,776 | 2,398 | 3,242 | 4,282 |
Net Cash (Debt) | 1,835 | 3,155 | 7,663 | 8,099 | 7,895 | 3,752 |
Net Cash Growth | -72.94% | -58.83% | -5.38% | 2.58% | 110.42% | - |
Net Cash Per Share | 56.47 | 97.09 | 235.81 | 249.22 | 242.95 | 115.75 |
Filing Date Shares Outstanding | 32.5 | 32.5 | 32.5 | 32.5 | 32.5 | 32.5 |
Total Common Shares Outstanding | 32.5 | 32.5 | 32.5 | 32.5 | 32.5 | 32.5 |
Working Capital | 17,849 | 15,649 | 17,274 | 16,455 | 15,247 | 10,921 |
Book Value Per Share | 1131.24 | 1112.36 | 972.00 | 848.36 | 796.23 | 656.03 |
Tangible Book Value | 36,678 | 36,059 | 31,513 | 27,464 | 25,741 | 21,138 |
Tangible Book Value Per Share | 1128.67 | 1109.62 | 969.73 | 845.13 | 792.11 | 650.46 |
Land | 1,461 | - | - | - | - | - |
Buildings | 10,146 | - | - | - | - | - |
Machinery | 14,609 | - | - | - | - | - |